Atara Biotherapeutics (ATRA) FCF Margin (2021 - 2026)
Atara Biotherapeutics (ATRA) posted FCF Margin of 595.54% for Q1 2026, down 66.74% on a QoQ basis from 357.18% in Q4 2025, and down 56687.0% year-over-year from N/an in Q1 2025.
Atara Biotherapeutics (ATRA) FCF Margin (2021 - 2026) Analysis & Trends
Atara Biotherapeutics' FCF Margin history runs 6 years deep, the most recent figure standing at 595.54% for Q1 2026.
- Quarterly FCF Margin fell 56687.0% year-over-year to 595.54% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 111.82% (down 7803.0% YoY) and the FY2025 annual result came in at 42.18%, up 1131.0% from the prior year.
- FCF Margin was 595.54% for Q1 2026 at Atara Biotherapeutics, down from 357.18% in the prior quarter.
- Across five years, FCF Margin topped out at 1600.8% in Q4 2023 and bottomed at 32621.95% in Q2 2023.
- A 5-year average of 2766.81% and a median of 201.33% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin tumbled 3250273 bps — and 2024, when it jumped 3258424 bps.
- Atara Biotherapeutics' FCF Margin stood at 3209.59% in 2022, then soared by 150 bps to 1600.8% in 2023, then plunged by 105 bps to 74.99% in 2024, then sank by 376 bps to 357.18% in 2025, then plunged by 67 bps to 595.54% in 2026.
- Business Quant data shows ATRA's FCF Margin at 595.54% in Q1 2026, 357.18% in Q4 2025, and 283.43% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | -595.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -595.54% |
| Dec 31, 2025 | -357.18% |
| Sep 30, 2025 | -283.43% |
| Jun 30, 2025 | -41.64% |
| Mar 31, 2025 | -28.67% |
| Dec 31, 2024 | -74.99% |
| Sep 30, 2024 | -9.93% |
| Jun 30, 2024 | -37.71% |
| Mar 31, 2024 | -108.24% |
| Dec 31, 2023 | 1,600.80% |
| Sep 30, 2023 | -2,555.79% |
| Jun 30, 2023 | -32,621.95% |
| Mar 31, 2023 | -4,369.12% |
| Dec 31, 2022 | -3,209.59% |
| Sep 30, 2022 | -1,456.83% |
| Jun 30, 2022 | -119.22% |
| Dec 31, 2021 | -457.74% |
| Sep 30, 2021 | -1,053.59% |
| Jun 30, 2021 | -1,644.39% |
| Mar 31, 2021 | -1,911.46% |